PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 28, 2026Neurobiology of Disease0 citationsOpen Access

lncRNA 3222401L13Rik/ENSG00000272070 modulates microglial inflammatory programs in association with PU.1

View Full Paper
RPRanjit PradhanMSM. Sadman SakibLKLalit Kaurani

Key Points

  • To investigate the role of lncRNA Glelr in modulating microglial inflammatory processes and its relationship with PU.1 transcription factor.
  • Examined expression of Glelr/GLELR in astrocytes and microglia in aging models.
  • Performed knockdown of Glelr in primary microglia to assess inflammatory responses.
  • Conducted RNA-sequencing to identify transcriptional changes in microglial pathways.
  • Analyzed expression of GLELR in postmortem Alzheimer's disease brain samples.
  • Glelr expression increases with age in microglia and astrocytes.
  • Knockdown of Glelr leads to higher TNFα expression and greater phagocytic activity in microglia.
  • RNA-sequencing reveals significant transcriptional activation of TNF and complement signaling pathways.
  • GLELR expression is reduced in Alzheimer's disease brains, correlating with increased inflammatory gene expression.

Abstract

Long non-coding RNAs (lncRNAs) are emerging as key regulators of brain function, but their contribution to microglial aging and neurodegenerative disease remains largely unknown. Because only 1.5% of the human genome encodes proteins, whereas the vast majority of transcripts belong to the largely unexplored non-coding RNAome, elucidating the functions of non-coding RNAs provides an unprecedented opportunity to expand the space for therapeutic discovery. We recently identified the glia-enriched lncRNA Glelr as upregulated in the aging mouse hippocampus. Here, we investigated its function in microglia and its human homolog GLELR . We found that Glelr/GLELR is expressed in both astrocytes and microglia and increases with age. Knockdown of Glelr in primary microglia led to enhanced expression of pro-inflammatory cytokines, including TNFα, and increased phagocytic activity. RNA-sequencing revealed widespread transcriptional changes enriched for TNF and complement signaling pathways. The human homolog GLELR showed conserved functions in iPSC-derived microglia, where its loss similarly promoted inflammatory gene expression and phagocytosis. Mechanistically, Glelr interacts with the microglial transcription factor PU.1, and its depletion overlapped with PU.1-driven transcriptional programs. Consistent with these findings, GLELR expression was significantly reduced in postmortem Alzheimer's disease (AD) brains, and AD-associated genes were enriched among Glelr -regulated targets. Together, our results identify Glelr / GLELR as a conserved, aging-associated lncRNA that modulates microglial inflammatory states through interaction with PU.1. This work links glial lncRNA regulation to AD-related neuroinflammation and suggests GLELR as a potential molecular target to fine-tune microglial activity in neurodegenerative diseases. • Glelr is a glia-enriched long non-coding RNA regulating microglial state. • Knockdown of Glelr increases TNFα signaling. • The human homolog GLELR shows reduced expression in AD brains. • Glelr interacts with the AD-associated transcription factor PU.1. • A conserved Glelr –PU.1 axis modulates microglial inflammation in aging and disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pradhan et al. (2026) studied this question.

synapsesocial.com/papers/69c770888bbfbc51511e0996https://doi.org/10.1016/j.nbd.2026.107366
Ask AI
Helpful
Bookmark
Share
View Full Paper